Menu

Tiny Shrimp Mix Up the Ocean

Crowds of zooplankton swimming upward generate large downward jets of water, a study finds.

Apr 18, 2018
Catherine Offord

Brine shrimp illuminated by an LED array swim upward in a water tank (4x speed) ISABEL HOUGHTON

Tiny shrimp and other zooplankton swimming in the ocean could play a major role in ocean mixing, according to researchers at Stanford University. The team reports that as large numbers of the creatures swim upward towards light during the day, they generate downward jets—a finding that suggests the animals could have substantial effects on the structure and composition of the world’s oceans. The results were published today (April 18) in Nature.

“Whether or not swarming adds up to genuine mixing has been the big question in this business for the past decade or so,” Nicholas Butterfield, a paleobiologist at the University of Cambridge who was not involved with the work, tells Science. “This study makes a pretty good claim for nailing it.”

To simulate a tiny piece of the ocean in the lab, Stanford biophysicist John Dabiri and colleagues set up two large tanks of water, and added more than 100,000 brine shrimp, Artemia salina, to each. Then, they encouraged the shrimp to swim upward with lights, and visualized the effects using several imaging techniques.

The team found that even when the water in the tanks was stratified—that is, it contained distinct sections differing in salinity and therefore density—the collective movement of many shrimp swimming upward resulted in large, downward jets of water.

The movement has yet to be observed in the open ocean, the authors note in their paper. However, “the results illustrate the potential for marine zooplankton to considerably alter the physical and biogeochemical structure of the water column,” the authors write, “with potentially widespread effects owing to their high abundance in climatically important regions of the ocean.”

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.